Ontology highlight
ABSTRACT: Purpose
To assess longitudinally the effect of anti-vascular endothelial growth factor (VEGF) treatment on ellipsoid zone (EZ) integrity, subretinal hyperreflective material (SHRM), and the sub-retinal pigment epithelium (sub-RPE) compartment in eyes with neovascular age-related macular degeneration (nAMD).Design
Post hoc analysis of the OSPREY clinical trial, a prospective, double-masked, phase 2 study comparing brolucizumab 6 mg with aflibercept 2 mg over 56 weeks.Participants
Participants with treatment-naïve nAMD at the initiation of the trial were included in the analysis.Methods
Eyes were evaluated with spectral-domain OCT at 4-week intervals in the OSPREY trial (n = 81). Spectral-domain OCT scans collected from each visit were segmented automatically
SUBMITTER: Ehlers JP
PROVIDER: S-EPMC8387490 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature